Does VINCRISTINE Cause Malignant neoplasm progression? 1,454 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,454 reports of Malignant neoplasm progression have been filed in association with VINCRISTINE (VinCRIStine Sulfate). This represents 2.0% of all adverse event reports for VINCRISTINE.
1,454
Reports of Malignant neoplasm progression with VINCRISTINE
2.0%
of all VINCRISTINE reports
516
Deaths
249
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VINCRISTINE?
Of the 1,454 reports, 516 (35.5%) resulted in death, 249 (17.1%) required hospitalization, and 91 (6.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINCRISTINE. However, 1,454 reports have been filed with the FAERS database.
What Other Side Effects Does VINCRISTINE Cause?
Febrile neutropenia (8,676)
Off label use (6,562)
Disease progression (5,252)
Neutropenia (4,982)
Drug ineffective (4,084)
Pyrexia (3,460)
Product use in unapproved indication (3,073)
Thrombocytopenia (2,940)
Sepsis (2,791)
Anaemia (2,603)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VINCRISTINE Alternatives Have Lower Malignant neoplasm progression Risk?
VINCRISTINE vs VINDESINE
VINCRISTINE vs VINORELBINE
VINCRISTINE vs VINORELBINE\VINORELBINE
VINCRISTINE vs VIREAD
VINCRISTINE vs VISIPAQUE